Analyst firms · Raymond James · ALHC
Raymond James ALHC price target and rating history
Alignment Healthcare Inc. (ALHC) · Health Care
Raymond James rates Alignment Healthcare Inc. (ALHC) Outperform with a $19 price target, as of its latest action on Aug 3, 2026. It has published 6 rating actions on ALHC since August 2021, including 2 upgrades and 2 downgrades.
- Current rating
- Outperform
- Price target
- $19
- Median target, all firms
- Too few
- Actions on ALHC
- 6
Raymond James price target on ALHC
Every Raymond James rating on ALHC
- Aug 3, 2026
- Oct 16, 2023
- May 1, 2023
- Nov 21, 2022
- Jan 12, 2022
- Aug 12, 2021
How other firms rate ALHC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| KeyBanc Capital Markets | Sector Weight | Oct 30, 2026 | |
| Needham | Hold | Oct 28, 2026 | |
| William Blair | Mkt Perform | Oct 9, 2026 | |
| Raymond James | Outperform | $19 | Aug 3, 2026 |
| Wolfe Research | Outperform | $24 | Apr 17, 2026 |
Questions about Raymond James and ALHC
- What is Raymond James's price target for ALHC?
- Raymond James's latest stated price target for Alignment Healthcare Inc. (ALHC) is $19, from its action on Aug 3, 2026.
- What is Raymond James's rating on ALHC?
- Raymond James rates ALHC Outperform, a bullish rating, as of Aug 3, 2026.
- When did Raymond James last change its view on ALHC?
- On Aug 3, 2026, Raymond James downgrades to Outperform from Strong Buy, price target $19.
More ALHC rating histories
All Raymond James ratingsALHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.